Albany, NY -- (SBWire) -- 12/19/2018 --The global Europe molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market is projected to show significant growth during the forecast period from 2015 to 2023, as per the analysis done by Transparency Market Research (TMR).

Europe has been facing number of incidences related to streptococcus pyogenes infection that has increased the demand for molecular diagnostic test. Thus, to provide effective measures with advanced technology have certainly grown the market in Europe. F. Hoffmann-La Roche Ltd. dominate the market, also there are other players contributing in the molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) tests in Europe such as Nanosphere, Inc., Alere, Inc., Hologic, Inc., and Meridian Bioscience Inc.

According to TMR, the Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products Market in Europe is projected to expand at a CAGR of 11.6% and its valuation is estimated to reach US$ 22.3 mn by the end of forecast period in 2023. As per the technique used, polymerase chain reaction segment use to hold the largest share in the molecular diagnostic market until 2014.

However, with increased technological advancements such as amplification technology used in isothermal nucleic acid will accelerate during the forecast period for it rapid identification and accuracy. Moreover, regional assessments states that Western Europe leads the market by controlling 48.9% of the market share. Northern Europe is also expected to show growth during the forecast period.

In Europe, the frequency of group A streptococcal disease (GAS) per years has approximately reached to 2.45 per lakh population in developed regions. The steady growth of this disease is evidently seen mainly the developed countries. Adoption of advanced technology in nucleic acid testing and its mass acceptance will certainly result in increasing the demand for molecular diagnostic market during the forecast period in Europe.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10505

Additionally, technology for nucleic acid testing has shifted from laboratory testing to point of care testing that has also increased the usage of molecular diagnostic testing among the huge population. Furthermore, amplification technique used in nucleic acid testing picks miniscule amount of RNA or DNA and the replicate them a couple of times that helps in detecting even a tiny trace of an organism in a specimen, which further avoid the need for culture.

Despite the drivers boosting the demand for molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market in Europe, there are certain restraining factors which may restrict the market to grow at its full potential.

In certain places, there is slow adoption of theses testing technology. Moreover, lack of facilities and ineffectiveness while providing molecular diagnostic testing may obstruct the market and can hinder its growth. To a certain extent, regulatory factors are also hampering the market to grow effectively. However, upcoming technologies are expected to generate more opportunities for the nucleic acid tests market that will help in increasing the demand for molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test products market.

The information presented in this review is based on a TMR report, titled "Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products (By Technique: Polymerase chain reaction, Non-amplified tests, and Isothermal nucleic acid amplification technology; By End-User: Hospitals, Public health laboratories, and Others) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023."

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10505

For the study, the European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Tests Products has been segmented into:

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Tests Products, by Type of Technique

-Isothermal nucleic acid amplification technology (iNAT)

-Polymerase chain reaction

-Non-amplified Tests

European Molecular Diagnostic Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Products, by End-user

-Hospitals

-Public Health Laboratories

-Others (referenced and clinical laboratories)

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com